Form D · Pharmaceuticals
ELITE PHARMACEUTICALS INC /NV/
Northvale, NJ · CIK 0001053369
Offering snapshot reported Jul 13, 2020 · SEC filing
- Reported sold
- $500K Offering amount: $26M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jul 8, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
| May 10, 2017 | Initial | $800,000 | No comparison | 1 | SEC filing |
| Apr 15, 2014 | Initial | $800,000 | No comparison | 1 | SEC filing |
| Apr 23, 2013 | Initial | $205,038 | No comparison | 1 | SEC filing |
| Jun 12, 2009 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 24, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370807
Amounts include common stock issued and issuable to Lincoln Park Capital as commitment and additional commitment shares under the purchase agreement.
Source: Form D, filed Jul 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Davis Caskey | Director |
| Barry Dash | Director |
| Chris Dick | Director, Executive |
| Mark Gittelman | Executive |
| Nasrat Hakim | Director, Executive |
| Robert J. Levenson | Director |
| Jeenarine Narine | Director |
| Ashok Nigalaye | Director, Executive |
| Eugene Pfeifer | Director |
| Douglas Plassche | Executive |
| Jerry Treppel | Director |
| Melvin Van Woert | Director |
| Carter Ward | Executive |
| Jeffrey Whitnell | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
165 Ludlow Avenue
Northvale, NJ, 07647
Northvale, NJ, 07647